Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging (Q39473687)

12 September 2017

title

Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging (English)

1 reference

12 September 2017

0 references

0 references

0 references

0 references

hepatocellular carcinoma

1 reference

K C Sia

1

1 reference

12 September 2017

H Huynh

2

1 reference

12 September 2017

N Chinnasamy

3

1 reference

12 September 2017

K M Hui

4

1 reference

12 September 2017

P Y P Lam

5

1 reference

12 September 2017

publication date

15 September 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

532-542

1 reference

Screening and treatment for hepatocellular carcinoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Treatment of hepatocellular carcinoma: too many options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Molecular imaging of gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Noninvasive bioluminescence imaging in small animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Methods to monitor gene therapy with molecular imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Switching on the lights for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Polycistronic viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

E unum pluribus: multiple proteins from a self-processing polyprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Efficient multicistronic expression of a transgene in human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Preventing growth of brain tumors by creating a zone of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

BAY 43-9006 inhibition of oncogenic RET mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Weekly administration of paclitaxel: theoretical and clinical basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

7 January 2021

Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

7 January 2021

Xenografts of human hepatocellular carcinoma: a useful model for testing drugs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

7 January 2021

Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

7 January 2021

Development of a destabilized firefly luciferase enzyme for measurement of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.131

7 January 2021

Identifiers

DOI

10.1038/GT.2011.131

1 reference

release_5ai2o5yefbejvj2bqvh2zzmm6e

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5ai2o5yefbejvj2bqvh2zzmm6e

24 November 2022

mapped directly with Wikidata item

1 reference